CD80 and neoplasm: Soluble PD-1 (sPD-1) is bioactive and blocks the three interactions of PD-L1:B7-1, PD-L1:PD-1 and PD-L2:PD-1 to restore T cell function and proliferation and enhance immune-mediated tumor control (40–46).